Retirement Systems of Alabama boosted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 0.2% in the fourth quarter, HoldingsChannel reports. The firm owned 215,084 shares of the company’s stock after purchasing an additional 481 shares during the quarter. Retirement Systems of Alabama’s holdings in HealthEquity were worth $20,637,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Holocene Advisors LP bought a new stake in HealthEquity in the 3rd quarter valued at $1,246,000. GSA Capital Partners LLP bought a new stake in shares of HealthEquity in the third quarter valued at about $638,000. Natixis Advisors LLC grew its stake in shares of HealthEquity by 29.8% in the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock valued at $17,122,000 after acquiring an additional 48,009 shares in the last quarter. Vaughan Nelson Investment Management L.P. increased its position in HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after acquiring an additional 226,563 shares during the period. Finally, Loomis Sayles & Co. L P raised its stake in HealthEquity by 2.2% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock worth $92,216,000 after purchasing an additional 24,665 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on HQY shares. Mizuho began coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. Bank of America increased their price target on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. BTIG Research lifted their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Royal Bank of Canada increased their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Finally, JMP Securities boosted their price target on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $110.71.
Insiders Place Their Bets
In other news, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the transaction, the director now owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. This trade represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.
HealthEquity Trading Up 0.1 %
HQY opened at $112.07 on Friday. The company’s 50 day moving average is $100.77 and its 200-day moving average is $89.34. The company has a market cap of $9.71 billion, a P/E ratio of 102.82, a PEG ratio of 1.94 and a beta of 0.55. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $113.22. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the firm posted $0.40 EPS. Equities research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading
- Five stocks we like better than HealthEquity
- How to Invest in the Best Canadian StocksĀ
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- Are Penny Stocks a Good Fit for Your Portfolio?
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Investing in the High PE Growth Stocks
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.